Adimmune CorporationTWSE: 4142

Change to the research and development officer of the company

· Issued by Adimmune Corporation
Close
Today's Information

Provided by: ADIMMUNE CORPORATION
SEQ_NO 1 Date of announcement 2022/01/26 Time of announcement 13:37:43
Subject
 Change to the research and development officer
of the company
Date of events 2022/01/26 To which item it meets paragraph 8
Statement
1.Type of personnel changed (please enter: spokesperson, acting
  spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
research and development officer, chief internal auditor, or
designated and non-designated representatives):Research and development
officer
2.Date of occurrence of the change:2022/01/26
3.Name, title, and resume of the previous position holder:Leo Leng,
Director/Research and development officer
4.Name, title, and resume of the new position holder:Dow Lee,
Director/Research and development officer
5.Type of the change (please enter: ��resignation��, ��position
adjustment��, ��dismissal��, ��retirement��, ��death�� or ��new
replacement��):Resignation
6.Reason for the change:Personal reason
7.Effective date:2022/01/26
8.Any other matters that need to be specified:None

Earlier from Adimmune

All Adimmune news releases